Skip to main navigation
  • Skip to main content
  • Skip to primary sidebar
Imara

Top Navigation

  • Careers
  • Contact Us

Investor Relations

  • Who We Are
    • Management
    • Board of Directors
  • Our Programs
    • IMR-687 & PDE9
    • Posters & Publications
    • Clinical Trials
  • Patients & Families
    • Resources
    • Advocacy Groups
    • Imara Expanded Access Policy
  • Investors
    • Press Releases
    • Events and Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
    • Contact IR
    • Email Alerts
  • Careers
  • Contact Us

Investors

Breadcrumb

Investors » Investor Relations

Investor Relations

Corporate Profile

Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, known as hemoglobinopathies. Our pipeline is built on the differentiated therapeutic potential of our lead product candidate, IMR-687, an oral, once-daily, potentially disease-modifying treatment in clinical development for sickle cell disease (SCD) and β-thalassemia. IMR-687 is uniquely designed as a highly selective, potent small molecule inhibitor of PDE9 with a multimodal mechanism that acts on red blood cells, white blood cells, adhesion mediators and other cell types. Our goal is to leverage the differentiated mechanism of action, ease of administration and stable drug properties of IMR-687 to potentially serve a broad range of patients suffering from hemoglobinopathies around the world, including those in underserved regions.
Change
Volume
52 Week High
52 Week Low
Mar 7, 2021 6:25 AM EST

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Press Releases
Mar 05, 2021
Imara Reports Full Year 2020 Financial Results and Business Highlights
Feb 26, 2021
Imara to Webcast Conference Call of Full Year 2020 Financial Results and Business Highlights
Feb 19, 2021
Imara to Present at SVB Leerink 10th Annual Global Healthcare Conference
Events
Mar 5, 2021 at 8:30 AM EST
Imara Inc Q4 Earnings Conference Call & Webcast
Feb 26, 2021 at 1:40 PM EST
SVB Leerink 10th Annual Global Healthcare Conference
Nov 5, 2020 at 8:30 AM EST
Imara Inc Q3 Earnings Conference Call & Webcast

Footer Social Link

Imara, Inc.
116 Huntington Ave.
6th Floor
Boston, MA 02116
T: 617-206-2020
E: info@imaratx.com

Sign Up for Email Updates
Privacy Policy
Terms of Use
© 2021 Imara, Inc.